Editorial ArticleClinical Diagnostics
Redefining the future of post-transplant care with personalized immunosupression
Dr. Richard Knight, medical director of transplant diagnostics at Thermo Fisher Scientific explores personalized, non‑invasive approaches designed to improve transplant success